InvestmentJun 10, 2026, 05:26 PM
Tango Therapeutics Raises $566.5M in Public Offering
AI Summary
Tango Therapeutics entered into an underwriting agreement for a public offering of 18,166,667 shares of common stock and 1,833,395 pre-funded warrants. The offering is expected to generate approximately $566.5 million in net proceeds. The company plans to use these funds for general corporate purposes, including research and development, pivotal trials, and potential commercialization, extending its cash runway into 2030.
Key Highlights
- Raised approximately $566.5 million in net proceeds from the offering.
- Offered 18,166,667 shares of common stock and 1,833,395 pre-funded warrants.
- Common stock offered at $30.00 per share; pre-funded warrants at $29.999.
- Underwriters have a 30-day option to purchase up to 3,000,009 additional shares.
- Proceeds will fund R&D, pivotal trials, and potential commercialization.
- Expected to extend the company's cash runway into 2030.
Price Impact
More from TNGX